Navigation Links
Broad Stakeholder Coalition Concludes that the 'Pathway for Biosimilars Act' Fails to Ensure Timely Access to Safe, Affordable Biogeneric Medicines for Patients

WASHINGTON, March 14 /PRNewswire-USNewswire/ -- The Coalition for a Competitive Pharmaceutical Market (CCPM) -- the organization representing a broad range of pharmaceutical stakeholders, including large national employers, insurers, pharmacies and generic drug manufacturers -- strongly urges Congress to develop legislation that will provide safe, effective and affordable biogenerics to consumers. This legislation must provide an appropriate balance between innovation and access to affordable biogenerics through competition.

The Pathway for Biosimilars Act will not bring timely patient access to safe and affordable biogeneric medicines as it fails to provide for a workable approval pathway or promote much needed competition in the biopharmaceutical marketplace. Under the Pathway for Biosimilars Act, it will be at least a decade before patients have access to more affordable biopharmaceuticals.

"It is widely acknowledged that the science exists to permit FDA to approve safe and effective comparable and interchangeable biogeneric products," said Katie Huffard, Executive Director of CCPM. "We urge Congress to create a workable pathway that relies on the FDA's scientific expertise to assure safety and effectiveness -- a pathway that ensures no undue delays to market entry and enhanced patient choice."

CCPM has worked diligently in a bipartisan fashion to help pass legislation that provides patients and their physicians access to safe, effective biogeneric medicines. CCPM supports passage of legislation this year that achieves these goals and will continue to work for balanced legislation this year and look for opportunities for compromise. To ensure that consumers, businesses and our health care system truly benefit from biogenerics legislation, Congress must pass a bill that:

-- Creates a workable FDA approval process for both comparable and interchangeable products

-- Provides for timely resolution of patent disputes

-- Encourages innovation by both brand and generic companies without requiring excessive, unprecedented, and unjustified market exclusivity, data exclusivity or patent extension provisions

CCPM urges members of the House of Representatives to return to the fundamental principles embodied in the bipartisan Access to Life Saving Medicines Act. This legislation, which is supported by consumer and patient advocates, employers, health plans, pharmacies and others, would create a meaningful and workable FDA approval pathway without excessive barriers to timely consumer access.

"American purchasers of pharmaceuticals are looking for action, but the bill must appropriately balance innovation and competition." said Huffard. "Congress has the ability to pass a landmark bill that will make a difference in the health of countless Americans. We well recognize that compromise will be required, but the Pathway for Biosimilars Act fails to make meaningful steps in this regard. We urge Members of Congress from both parties to ensure the pathway works for patients, employers, health plans as well as brand and generic industries."

CCPM supports public policies that facilitate timely access to affordable pharmaceuticals. Visit for more information and a list of CCPM members.

SOURCE Coalition for a Competitive Pharmaceutical Market
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. Euro RSCG Life Broadens X2 Expertise
3. Revolutionary HD Surgical Footage from North Shore-LIJ Surgeon to be Broadcast for the First Time on ABCs 20/20, National Geographic Channel
4. Drug Detection Kits Manufactured By IDenta Corp. Shown During French Television Broadcast (at TF1) - Product Aids French Police In Bust of 600 Kilograms Of Cocaine
5. SATELLITE BROADCAST: Consumer Group Says Hillary Clintons Mandatory Health Insurance Plan is an Act of War on the Middle Class that Cant Afford $12k Policy
6. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
7. Incidental findings found when radiologists take a broader look at renal MRA
8. Sanarus Announces Partnership With Leading US Breast Care Physicians for the Next Generation Visica 2(TM) Treatment System for Fibroadenomas
9. Staffing Agency Hires Local Television News Team, Launches Broadband Network for Nurses
10. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
11. Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship
Post Your Comments:
(Date:10/13/2015)... ... , ... Symposium Chairman, Dr. Rod J. Rohrich is pleased to announce that ... March 2nd and 3rd, 2016. The annual meeting, along with the Dallas Rhinoplasty ... around the world. , Key topics at this year's event will include discussions on ...
(Date:10/13/2015)... ... October 13, 2015 , ... Relay (, a ... announced today a significant contract that will provide its award-winning private messaging solution ... on the growing success of its Relay program, IBX Wire™, which now has ...
(Date:10/13/2015)... ... October 13, 2015 , ... NavaFit Inc. today announced the launch of ... train with, participate in local fitness & sporting events, and stay motivated. ... high medical costs drive us to get more serious about fitness and wellness, individuals ...
(Date:10/13/2015)... Boston, MA (PRWEB) , ... October 13, 2015 , ... ... mortar of the body, including muscle, bone, and blood. But how much protein does ... more complicated than it might seem, according to the October 2015 issue of ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... Scientists in ... tissue biopsy in 18 patients with or without mesothelioma. Surviving Mesothelioma has just posted ... , The doctors from PhenoPath Laboratories in Seattle and the University of British Columbia ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... , Oct. 13, 2015  Data Science Automation (DSA), ... opening of a new branch office in the ... DSA,s presence in Europe . The decision ... increasing demand for local support of customers in the medical ... Ph.D., DSA,s UK Branch Manager. "We have had tremendous success ...
(Date:10/13/2015)... -- SeraCare Life Sciences, a leading partner to global in ... medicine business unit has launched its second product in ... (NGS)-based tumor profiling assays.  The Seraseq TM Solid ... mutations in key oncogenes and tumor suppressor genes as ... is offered at five additional allele frequencies. ...
(Date:10/13/2015)... , Oct. 13, 2015  Graduate students across ... and medical research, will soon have the opportunity ... care – the drug discovery and development process. ... has collaborated with 10 leaders from academic institutions ... Medicines: The Process of Drug Development."  Lilly will ...
Breaking Medicine Technology: